Donation

ASH
Image
microscope examining film
ASH 2021 Noopur Raje BB21217
ASH
December 17
Updated Clinical and Correlative Results from the Phase I CRB-402 Study of the BCMA-Targeted CAR T Cell Therapy bb21217 in Patients with Relapsed and Refractory Multiple Myeloma
Best of ASH 2021
ASH
December 16
Best of ASH 2021 Webinar
ASH21 Luciano Costa Final Results from MASTER trial
ASH
December 16
Dara-KRd, Autologous Transplantation and MRD Response-Adapted Consolidation and Treatment Cessation. Final Primary Endpoint Analysis of the MASTER Trial
ASH 2021 global t1114
ASH
December 15
Global Treatment Patterns and Outcomes Among Patients with Chromosome Translocation (11;14)-Positive Multiple Myeloma
ASH 2021 First-in-Human Study of Tnb-383B
ASH
December 15
A Phase 1 First-in-Human Study of TNB-383B, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
ASH 2021 Shaji Kumar BELLINI study
ASH
December 15
Final Overall Survival Results from BELLINI, a Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma
ASH 2021 Hartmut Goldschimdt The Phase III GMMG-HD7 Trial
ASH
December 15
Addition of Isatuximab to RVd As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial
ASH 2021 Lonial Iberdomide
ASH
December 15
Iberdomide in Combination with Dexamethasone in Pts with Relapsed/Refractory Multiple Myeloma
ASH 2021 Long iStopMM Results
ASH
December 15
Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on iStopMM Study
ASH 2021 Sigrun Thorsteinsdottir Oral 151
ASH
December 15
Prevalence of Smoldering Multiple Myeloma: Results from the iStopMM Study
ASH 2021 Dan Vogl Modakafusp Alfa
ASH
December 14
Modakafusp Alfa (TAK-573), an Immunocytokine, in Patients with Relapsed/Refractory Multiple Myeloma; Updated Results from a First-in-Human Phase 1 Study
ASHJ 2021 Epidemiology and Risk Factors for the Development of Infectious Complications
ASH
December 14
Epidemiology and Risk Factors for the Development of Infectious Complications in Patients with Multiple Myeloma: A Multicenter Prospective Cohort Study in Latin America
Subscribe to ASH

Give Where Most Needed

Learn More